Literature DB >> 12654170

The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study.

Trine Madsen1, Jeppe H Christensen, Mogens Blom, Erik B Schmidt.   

Abstract

C-reactive protein (CRP) is a sensitive marker for low-grade inflammation. Long-chain n-3 polyunsaturated fatty acids (PUFA) have anti-inflammatory effects. The objective of the present study was to investigate the effect on serum levels of CRP of n-3 PUFA at two different doses. We also investigated correlations between CRP and the cellular contents of PUFA. Sixty healthy volunteers (twenty-five women and thirty-five men) were randomly assigned to three treatment groups in a double-blind design. The subjects received a supplement of either 6.6 g n-3 PUFA/d, 2.0 g n-3 PUFA/d or placebo (olive oil) for 12 weeks. CRP was measured using a highly sensitive assay. The median serum CRP concentration was 0.78 mg/l. No significant correlations were found between CRP and the content of n-3 PUFA in granulocytes or platelets. Subjects receiving n-3 PUFA had a significant (P<0.01) increase in the cellular contents of 20 : 5n-3, 22 : 5n-3 and 22 : 6n-3, with the largest increase occurring in the group receiving 6.6 g PUFA/d. A significant (P<0.01) decrease in cellular content of 18 : 2n-6 and 20 : 4n-6 was observed simultaneously. Serum CRP concentrations, however, were unaffected by the PUFA-containing supplements. The present study shows that dietary supplementation with PUFA-containing supplements has no effect on serum concentrations of CRP, measured with a highly sensitive assay, in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654170     DOI: 10.1079/BJN2002815

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  24 in total

Review 1.  The evidence for α-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid.

Authors:  Jennifer A Fleming; Penny M Kris-Etherton
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

2.  C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study.

Authors:  Trine Madsen; Jeppe H Christensen; Erik B Schmidt
Journal:  Eur J Nutr       Date:  2007-08-04       Impact factor: 5.614

3.  C-reactive protein is associated with heart rate variability.

Authors:  Trine Madsen; Jeppe Hagstrup Christensen; Egon Toft; Erik Berg Schmidt
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

4.  Plasma levels of 14:0, 16:0, 16:1n-7, and 20:3n-6 are positively associated, but 18:0 and 18:2n-6 are inversely associated with markers of inflammation in young healthy adults.

Authors:  Maude Perreault; Kaitlin Roke; Alaa Badawi; Daiva E Nielsen; Salma A Abdelmagid; Ahmed El-Sohemy; David W L Ma; David M Mutch
Journal:  Lipids       Date:  2013-12-15       Impact factor: 1.880

5.  Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome.

Authors:  Antonella Dewell; Farshad Fani Marvasti; William S Harris; Philip Tsao; Christopher D Gardner
Journal:  J Nutr       Date:  2011-10-26       Impact factor: 4.798

Review 6.  Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation in Patients with Atrial Fibrillation.

Authors:  Sanjay Kumar; Sarah Qu; John T Kassotis
Journal:  J Atr Fibrillation       Date:  2012-08-20

7.  Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids.

Authors:  Z Makhoul; A R Kristal; R Gulati; B Luick; A Bersamin; D O'Brien; S E Hopkins; C B Stephensen; K L Stanhope; P J Havel; B Boyer
Journal:  Eur J Clin Nutr       Date:  2011-03-23       Impact factor: 4.016

8.  A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study.

Authors:  V D F de Mello; U Schwab; M Kolehmainen; W Koenig; M Siloaho; K Poutanen; H Mykkänen; M Uusitupa
Journal:  Diabetologia       Date:  2011-08-26       Impact factor: 10.122

9.  Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos.

Authors:  Zeina Makhoul; Alan R Kristal; Roman Gulati; Bret Luick; Andrea Bersamin; Bert Boyer; Gerald V Mohatt
Journal:  Am J Clin Nutr       Date:  2010-01-20       Impact factor: 7.045

Review 10.  Review of Cardiometabolic Effects of Prescription Omega-3 Fatty Acids.

Authors:  Megan F Burke; Frances M Burke; Daniel E Soffer
Journal:  Curr Atheroscler Rep       Date:  2017-11-07       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.